Fig. 4: TKI efficacy by ELN criteria.
Overall survival in patients treated with higher intensity chemotherapy by TKI use within ELN 2017 risk categories, (a) favorable (b) intermediate (c) unfavorable.
Fig. 4: TKI efficacy by ELN criteria. | Blood Cancer Journal
